Hainan Huluwa Pharmaceutical Group Co., Ltd. (SHA:605199)

Market Cap	4.97B
Revenue (ttm)	1.86B
Net Income (ttm)	111.27M
Shares Out	400.11M
EPS (ttm)	0.29
PE Ratio	42.64
Forward PE	n/a
Dividend	0.13 (1.01%)
Ex-Dividend Date	n/a

Volume	69,400
Average Volume	9,661,985
Open	12.41
Previous Close	13.06
Day's Range	12.41 - 12.41
52-Week Range	9.09 - 25.16
Beta	0.68
RSI	31.54
Earnings Date	Apr 29, 2025

About SHA:605199

Hainan Huluwa Pharmaceutical Group Co., Ltd. research, develops, produces, and sells drugs in the areas of Children's digestive system, respiratory system, anti-infection, anti-virus and other therapeutic in China. It offers pediatrics, gynecology, antibiotics, respiratory, digestive system, cardiovascular and cerebrovascular, nourishment, and other medicine products. The company was founded in 2005 and is based in Haikou, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2005
• Employees: 2,468
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 605199

Financial Performance

In 2023, SHA:605199's revenue was 1.91 billion, an increase of 25.75% compared to the previous year's 1.52 billion. Earnings were 106.50 million, an increase of 24.29%.